Stephen Howell, MDUniversity of California San Diego Dendrimer-folate targeting of paclitaxel to ovarian cancer Paclitaxel is used extensively for the treatment of ovarian cancer. The overall goal of this project is to test the efficacy and toxicity of a novel paclitaxel drug delivery system, capable of selectively targeting ovarian cancers and thereby increasing tumor cell […]
Read More
Carol Hanchette, PhDUniversity of Louisville Ovarian Cancer and Pulp and Paper Manufacturing in the US: A Geospatial Analysis The primary aim of Dr. Hanchette‘s project is to discover whether high rates of ovarian cancer occurrence in the United States correspond with the locations of pulp and paper mills. An association between the two has been […]
Read More
Martin Cannon, PhDUniversity of Arkansas for Medical Science Dendritic cell vaccination & inhibition of tumor-associated immune suppression Recent clinical studies have found that ovarian cancer patients with Th17 lymphocyte infiltrates in tumors enjoy a markedly longer overall survival, suggesting that Th17 cells play a protective role against ovarian cancer. Dr. Cannon designed an innovative approach […]
Read More